Skip to main content

Advertisement

SpringerLink
Log in

Lupus and leprosy: beyond the coincidence

  • DIAGNOSTICS AND ENVIRONMENTAL FACTORS
  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

Systemic lupus erythematous (SLE) is an autoimmune disease that presents an increased susceptibility to infections which may trigger reactivation. Disease flares have been mostly associated with parvovirus B19, cytomegalovirus, EBV and Mycobacterium tuberculosis infections, but it is probable that many other agents may also induce innate and adaptive immune system stimulation including the production of autoantibodies as ANA, anti nDNA and anti-ß2-GPI mainly in lepromatous leprosy. Mycobacterium leprae not only may determine symptoms that mimic lupus flares, including autoantibodies production, but could also act as a trigger for lupus reactivation; however, its association is still not fully explored. As demonstrated for tuberculosis, it is quite possible that molecular mimicry may also be involved in the interface of these two diseases. Some studies reported shared epitopes among idiotypes derived from 8E7 and TH9 lepromatous antibodies and those obtained from SLE patients, and it could partially explain the triggering phenomenon of SLE caused by M. leprae. We report and discuss three Brazilian patients whose disease was inactive and presented disease flares concurrently with the diagnosis of leprosy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hsu TC, Tsay GJ. Human parvovirus B19 infection in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2001;40:152–7.

    Article  CAS  Google Scholar 

  2. Hemauer A, Beckenlehner K, Wolf H, Lang B, Modrow S. Acute parvovirus B19 infection in connection with a flare of systemic lupus erythematodes in a female patient. J Clin Virol. 1999;14:73–7.

    Article  CAS  PubMed  Google Scholar 

  3. Goddard GZ, Shoenfeld Y. Infections and SLE. Autoimmunity. 2005;38:473–85.

    Article  Google Scholar 

  4. Hayashi T, Lee S, Ogasawara H, Sekigawa I. Exacerbation of systemic lupus erythematosus related to cytomegalovirus infection. Lupus. 1998;7:561–4.

    Article  CAS  PubMed  Google Scholar 

  5. Francis L, Perl A. Infection in systemic lupus erythematosus: friend or foe? Int J Clin Rheumtol. 2010;5:59–74.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Ribeiro FM, Szyper-Kravitz M, Klumb EM, et al. Can lupus flares be associated with tuberculosis infection? Clin Rev Allergy Immunol. 2010;38:163–8.

    Article  CAS  PubMed  Google Scholar 

  7. Shoenfeld Y, Isenberg DA. Mycobacteria and autoimmunity. Immunol Today. 1988;9:178–81.

    Article  CAS  PubMed  Google Scholar 

  8. Sela O, El-Roeiy A, DA Isenberg J, et al. A common anti-DNA antibody idiotype in sera of patients with active pulmonary tuberculosis. Arthritis Rheum. 1987;30:50–5.

    Article  CAS  PubMed  Google Scholar 

  9. Carducci R, Teralbini CGL, Tak CG. Autoantibodies in leprosy. Int J Lepr. 1978;58:171–5.

    Google Scholar 

  10. Guedes Barbosa LS, Gilbrut B, Shoenfeld Y, Sheinberg MA. Autoantibodies in leprosy sera. Clin Rheumatol. 1996;15:26–8.

    Article  CAS  PubMed  Google Scholar 

  11. Eichelmann K, González González SE, Salas-Alanis JC, Ocampo-Candiani J. Leprosy. An update: definition, pathogenesis, classification, diagnosis, and treatment. Actas Dermosifiliogr. 2013;104:554–63.

    Article  CAS  PubMed  Google Scholar 

  12. Global leprosy situation. Wkly Epidemiol Rec. 2010;85:337–48.

    Google Scholar 

  13. Gulia A, Fried I, Massone C. New insights in the pathogenesis and genetics of leprosy. F1000 Medicine Reports. 2010;27:2.

    Google Scholar 

  14. Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL. The continuing challenges of leprosy. Clin Microbiol Rev. 2006;19:338–81.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Demangel C, Britton WJ. Interaction of dendritic cells with mycobacteria: where the action starts. Immunol Cell Biol. 2000;78:318–24.

    Article  CAS  PubMed  Google Scholar 

  16. Rodrigues LS, da Silva Maeda E, et al. Mycobacterium leprae induces insulin-like growth factor and promotes survival of Schwann cells upon serum withdrawal. Cell Microbiol. 2010;12:42–54.

    Article  CAS  PubMed  Google Scholar 

  17. Scollard DM, Smith T, Bhoopat L, Theetranont C, Rangdaeng S, Morens DM. Epidemiologic characteristics of leprosy reactions. Int J Lepr Other Mycobact Dis. 1994;1994(62):559–67.

    Google Scholar 

  18. Kumar B, Dogra S, Kaur I. Epidemiological characteristics of leprosy reactions: 15 years experience from North India. Int J Lepr Other Mycobact Dis. 2004;72:125–33.

    Article  PubMed  Google Scholar 

  19. Salvi S, Chopra A. Leprosy in a rheumatology setting: a challenging mimic to expose. Clin Rheumatol. 2013;32:1557–63.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Teixeira Júnior GJ, Silva CEF, Magalhães V. Application of the diagnostic criteria for systemic lupus erythematosus to patients with multibacillary leprosy. Rev Soc Bras Med Trop. 2011;44:85–90.

    Article  PubMed  Google Scholar 

  21. la Torre Garcia-de. I. Autoimmune phenomena in leprosy, particularly antinuclear antibodies and rheumatoid factor. J Rheumatol. 1993;20:900–3.

    Google Scholar 

  22. Kroumpouzos G, Vareltzidis A, Konstadoulakis MM, et al. Evaluation of the autoimmune response in leprosy. Lepr Rev. 1993;64:199–207.

    CAS  PubMed  Google Scholar 

  23. Miller RA, Wener MH, Harnisch JP, Gilliland BC. The limited spectrum of antinuclear antibodies in leprosy. J Rheumatol. 1987;14:108–10.

    CAS  PubMed  Google Scholar 

  24. Sharma VK, Saha K, Sehgal VN. Serum immunoglobulins and autoantibodies during and after erythema nodosum leprosum (ENL). Int J Lepr Other Mycobact Dis. 1982;50:159–63.

    CAS  PubMed  Google Scholar 

  25. Masala C, Amendolea MA, Nuti M, Riccarducci R, Tarabini CG, Tarabini CG. Autoanibodies in leprosy. Int J Lepr Other Mycobac Dis. 1979;47:171–5.

    CAS  Google Scholar 

  26. Guedes-Barbosa LS, Gilbrut B, Shoenfeld Y, Scheinberg MA. Autoantibodies in leprosy sera. Clin Rheumatol. 1996;15:26–8.

    Article  CAS  PubMed  Google Scholar 

  27. Zandman-Goddard G, Blank M, Shoenfeld Y. Antiphospholipid antibodies and infections-drugs. In: Asherson RA, Cervera R, Piette JC, Shoenfeld Y, editors. The antiphospholipid syndrome II. Amsterdan: Elsevier Science; 2002. p. 343–60.

    Chapter  Google Scholar 

  28. Elbeialy A, Strassburger-Lorna K, Altsumi T, et al. Antiphospholipid antibodies in leprotic patients: a correlation with disease manifestation. Clin Exp Rheumatol. 2000;18:492–4.

    CAS  PubMed  Google Scholar 

  29. Loizou S, Singh S, Wypkema E, Asherson RA. Anticardiolipin anti- beta2-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease. Ann Rheum Dis. 2003;62:1106–11.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. de Laranaga GF, Forastiero RR, Martinuzzo ME, et al. High prevalence of antiphospholipid antibodies in leprosy: evaluation of antigen reactivity. Lupus. 2000;9:594–600.

    Article  Google Scholar 

  31. Bonfa E, Llovet R, Scheinberg M, de Souza JM, Elkon KB. Comparison between autoantibodies in malaria and leprosy with lupus. Clin Exp Immunol. 1987;70:529–37.

    CAS  PubMed Central  PubMed  Google Scholar 

  32. Hojnik M, Gilburd B, Ziporen L, et al. Anticardiolipin antibodies in infections are heterogeneous in their dependency on ß2-GPI: analysis of anticardiolipina antibodies in leprosy. Lupus. 1994;3:515–21.

    Article  CAS  PubMed  Google Scholar 

  33. Levy RA, Pierangeli SA, Espinola RG. Antiphospholipid beta-2 glycoprotein I dependency assay to determine antibody pathogenicity. Arthritis Rheuma. 2000;43(suppl):I476.

    Google Scholar 

  34. Ribeiro SLE, Pereira HLA, Silva NP, Souza AWS, Sato EI. Anti- ß2 glycoprotein I antibodies are highly prevalent in a large number of Brazilian leprosy patients. Acta Reumatol Port. 2011;36:30–7.

    CAS  PubMed  Google Scholar 

  35. Asherson RA, Shoenfeld Y. The role of infections in the pathogenesis of catasthrophic antiphospholipid syndrome—molecular mimicry? J Rheumatol. 2000;27:12–4.

    CAS  PubMed  Google Scholar 

  36. Shoenfeld Y, Isenberg DA. Mycobacteria and autoimmunity. Immunol Today. 1988;9:178–81.

    Article  CAS  PubMed  Google Scholar 

  37. Shoenfeld Y, Vilner Y, Coates AR, et al. Monoclonal anti- tuberculosis antibodies react with DNA and monoclonal anti- DNA autoantibodies react with Mycobacterium tuberculosis. Clin Exp Immunol. 1986;66:255–61.

    CAS  PubMed Central  PubMed  Google Scholar 

  38. Amital-Teplizic H, Avinoach I, Coates AR, Kooperman O, Blank M, Shoenfeld Y. Binding of monoclonal anti-DNA and anti-TB glycolipids to brain tissue. Autoimmunity. 1989;4:277–87.

    Article  Google Scholar 

  39. Sela O, El-Roeiy A, Isenberg DA, et al. A common anti-DNA antibody idiotype in sera of patients with active pulmonary tuberculosis. Arthritis Rheum. 1987;30:50–5.

    Article  CAS  PubMed  Google Scholar 

  40. Mackworth-Young CG, Sabbaga J, Schwartz RS. Idiotypic markers of polyclonal B cell activation. Public idiotypes shared by monoclonal antibodies derived from patients with systemic lupus erythematosus or leprosy. J Clin Invest. 1987;79:572–81.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  41. Mackworth-Young CG. Cross-reactive idiotypes in sera from patients with leprosy, lupus and Lyme disease and from healthy individuals. Clin Exp Immunol. 1990;79:78–82.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  42. Mackworth-Young CG, Cairns E, Sabbaga J, et al. Comparative study of idiotypes on monoclonal antibodies derived from patients with lupus and leprosy and from normal individuals. J Autoimmunity. 1990;3:415–9.

    Article  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Disciplina de Reumatologia, Universidade do Estado do Rio de Janeiro, Rua Dois de Dezembro, 131/702 - Flamengo, Rio de Janeiro, RJ, 22220-040, Brazil

    F. M. Ribeiro, V. E. Gomez, E. M. N. Albuquerque & E. M. Klumb

  2. Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel

    Y. Shoenfeld

  3. Incumbent of the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Tel-Aviv University, Tel-Hashomer, Israel

    Y. Shoenfeld

Authors
  1. F. M. Ribeiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. E. Gomez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. M. N. Albuquerque
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. M. Klumb
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Y. Shoenfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. M. Ribeiro.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ribeiro, F.M., Gomez, V.E., Albuquerque, E.M.N. et al. Lupus and leprosy: beyond the coincidence. Immunol Res 61, 160–163 (2015). https://doi.org/10.1007/s12026-014-8596-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12026-014-8596-y

Keywords

Search

Navigation